Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trialJuan W. Valle, John Bridgewater, Harpreet Wasan et al.|The Lancet Oncology|2015Cited by 282
Cancer cell survival depends on collagen uptake into tumor-associated stromaKuo-Sheng Hsu, Brad St. Croix, James M. Dunleavey et al.|Research Square|2022Cited by 5
SAPROCAN: Saracatinib (AZD0530) and docetaxel in metastatic,castrate-refractory prostate cancer (mCRPC)—A phase I/randomized phase II study by the United Kingdom National Cancer Research Institute Prostate Group.Robert J. Jones, Simon J. Crabb, Charlotte Westbury et al.|Journal of Clinical Oncology|2021Cited by 3